Verified Peptide ReviewLast reviewed: 15 February 2026
Compound Profile · Immune
KPV
KPV is a C-terminal tripeptide of α-MSH studied for anti-inflammatory pathways.
LegalResearch onlyEvidenceEmergingHuman useNot approved
7.2/ 10
Peptide Score
Evidence
Safety
Regulatory
Transparency
Quick verdict
Active preclinical research area for inflammation; human evidence remains limited.
Reality check
What this isn't
- Not approved for human use — research-only context
- No regulator has approved human use
- Evidence base is early — long-term data limited
- Side-effect profile not fully characterised
- Educational only — not medical advice
Full KPV review
A short tripeptide derived from α-MSH.
Looking at alternatives?
Compounds with comparable research interest but different evidence, regulatory status, or risk profile.